GARY W PACE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GARY W PACE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GARY W PACE. GARY W PACE is Director in RESMED INC ($RMD) and Director in Trovagene, Inc. ($XNOM.OB) and Director in Pacira Pharmaceuticals, Inc. ($PCRX).
Latest Insider Trading Transactions of GARY W PACE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XNOM.OB, PCRX, RMD
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.31 | 2,500 | 25,775 | 464,811 | 462.3 K to 464.8 K (+0.54 %) |
| Mar 24 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.21 | 2,500 | 25,525 | 462,311 | 459.8 K to 462.3 K (+0.54 %) |
| Mar 24 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.20 | 5,000 | 51,000 | 459,811 | 454.8 K to 459.8 K (+1.10 %) |
| Mar 19 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.54 | 2,000 | 21,080 | 454,811 | 452.8 K to 454.8 K (+0.44 %) |
| Mar 19 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.54 | 2,000 | 21,080 | 454,811 | 452.8 K to 454.8 K (+0.44 %) |
| Mar 19 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.58 | 1,000 | 10,580 | 452,811 | 451.8 K to 452.8 K (+0.22 %) |
| Mar 19 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.58 | 1,000 | 10,580 | 452,811 | 451.8 K to 452.8 K (+0.22 %) |
| Mar 04 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 9.27 | 1,500 | 13,898 | 451,811 | 450.3 K to 451.8 K (+0.33 %) |
| Sep 29 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 16.67 | 70,000 | 1,166,900 | 0 | |
| Sep 29 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 16.67 | 70,000 | 1,166,900 | 129,949 | 59.9 K to 129.9 K (+116.77 %) |
| Sep 17 2020 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 5.71 | 850 | 4,854 | 450,311 | 449.5 K to 450.3 K (+0.19 %) |
| Sep 17 2020 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 5.69 | 1,700 | 9,673 | 449,461 | 447.8 K to 449.5 K (+0.38 %) |
| Jun 19 2020 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Option Exercise | A | 2.60 | 28,858 | 75,031 | 40,774 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Grant | A | 0.00 | 1,260 | 0 | 59,949 | 58.7 K to 59.9 K (+2.15 %) |
| May 13 2020 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 1.34 | 447,761 | 600,000 | 447,761 | 0 to 447.8 K |
| May 01 2020 | XNOM.OB | Trovagene, Inc. | PACE GARY W | Director | Option Exercise | A | 0.98 | 11,916 | 11,678 | 11,916 | |
| Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 13.98 | 5,000 | 69,900 | 0 | |
| Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 1.61 | 7,438 | 11,975 | 0 | |
| Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 1.61 | 4,649 | 7,485 | 0 | |
| Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 1.61 | 4,649 | 7,485 | 0 | |
| Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 13.98 | 5,000 | 69,900 | 58,689 | 53.7 K to 58.7 K (+9.31 %) |
| Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 1.61 | 7,438 | 11,975 | 53,689 | 46.3 K to 53.7 K (+16.08 %) |
| Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 1.61 | 4,649 | 7,485 | 46,251 | 41.6 K to 46.3 K (+11.17 %) |
| Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 1.61 | 4,649 | 7,485 | 41,602 | 37 K to 41.6 K (+12.58 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Grant | A | 0.00 | 4,134 | 0 | 36,953 | 32.8 K to 37 K (+12.60 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Grant | A | 0.00 | 4,134 | 0 | 36,953 | 32.8 K to 37 K (+12.60 %) |
| Nov 21 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Buy | P | 46.18 | 4,500 | 207,810 | 32,819 | 28.3 K to 32.8 K (+15.89 %) |
| Nov 09 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Buy | P | 51.29 | 4,000 | 205,160 | 28,319 | 24.3 K to 28.3 K (+16.45 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 782 | 0 | 24,319 | 23.5 K to 24.3 K (+3.32 %) |
| May 10 2018 | RMD | RESMED INC | PACE GARY W | Director | Option Exercise | M | 27.58 | 28,403 | 783,355 | 0 | |
| May 10 2018 | RMD | RESMED INC | PACE GARY W | Director | Sell | S | 97.37 | 28,403 | 2,765,600 | 100,578 | 129 K to 100.6 K (-22.02 %) |
| May 10 2018 | RMD | RESMED INC | PACE GARY W | Director | Buy | M | 27.58 | 28,403 | 783,355 | 128,981 | 100.6 K to 129 K (+28.24 %) |
| Nov 17 2017 | RMD | RESMED INC | PACE GARY W | Director | Grant | A | 0.00 | 2,991 | 0 | 100,578 | 97.6 K to 100.6 K (+3.06 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 1,357 | 0 | 23,537 | 22.2 K to 23.5 K (+6.12 %) |
| Jun 16 2017 | RMD | RESMED INC | PACE GARY W | Director | Option Exercise | M | 33.70 | 22,660 | 763,642 | 0 | |
| Jun 16 2017 | RMD | RESMED INC | PACE GARY W | Director | Option Exercise | M | 33.70 | 1,730 | 58,301 | 22,660 | |
| Jun 16 2017 | RMD | RESMED INC | PACE GARY W | Director | Sell | S | 76.00 | 22,660 | 1,722,160 | 97,587 | 120.2 K to 97.6 K (-18.84 %) |
| Jun 16 2017 | RMD | RESMED INC | PACE GARY W | Director | Buy | M | 33.70 | 22,660 | 763,642 | 120,247 | 97.6 K to 120.2 K (+23.22 %) |
| Jun 16 2017 | RMD | RESMED INC | PACE GARY W | Director | Sell | S | 76.00 | 1,730 | 131,480 | 97,587 | 99.3 K to 97.6 K (-1.74 %) |
| Jun 16 2017 | RMD | RESMED INC | PACE GARY W | Director | Buy | M | 33.70 | 1,730 | 58,301 | 99,317 | 97.6 K to 99.3 K (+1.77 %) |
| Nov 17 2016 | RMD | RESMED INC | PACE GARY W | Director | Grant | A | 0.00 | 4,429 | 0 | 97,587 | 93.2 K to 97.6 K (+4.75 %) |
| Aug 22 2016 | RMD | RESMED INC | PACE GARY W | Director | Option Exercise | M | 25.54 | 36,000 | 919,440 | 0 | |
| Aug 22 2016 | RMD | RESMED INC | PACE GARY W | Director | Sell | S | 69.93 | 36,000 | 2,517,336 | 93,158 | 129.2 K to 93.2 K (-27.87 %) |
| Aug 22 2016 | RMD | RESMED INC | PACE GARY W | Director | Buy | M | 25.54 | 36,000 | 919,440 | 129,158 | 93.2 K to 129.2 K (+38.64 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 1,488 | 0 | 22,180 | 20.7 K to 22.2 K (+7.19 %) |
| Mar 14 2016 | RMD | RESMED INC | PACE GARY W | Director | Option Exercise | M | 23.88 | 36,000 | 859,500 | 0 | |
| Mar 14 2016 | RMD | RESMED INC | PACE GARY W | Director | Sell | S | 60.00 | 36,000 | 2,160,000 | 93,158 | 129.2 K to 93.2 K (-27.87 %) |
| Mar 14 2016 | RMD | RESMED INC | PACE GARY W | Director | Buy | M | 23.88 | 36,000 | 859,500 | 129,158 | 93.2 K to 129.2 K (+38.64 %) |
| Nov 23 2015 | RMD | RESMED INC | PACE GARY W | Director | Option Exercise | A | 58.24 | 20,492 | 1,193,454 | 20,492 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 2,000 | 0 | 20,692 | 18.7 K to 20.7 K (+10.70 %) |
| Mar 17 2015 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Buy | P | 93.83 | 1,000 | 93,830 | 18,692 | 17.7 K to 18.7 K (+5.65 %) |
Page: 1